investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Preclinical development of TIMP-2 as a biologic therapy for cancer

William Stetler-Stevenson

2 Collaborator(s)

Funding source

National Cancer Institute (NIH)
Our goal is to study the effects of TIMP-2 and Ala+TIMP-2 on the growth of brain tumors in a syngeneic murine model by intracranial and/or systemic administration.

Related projects

Alexandra Golby

Multimodal Registration of the Brain's Cortical Surface

Brain, nervous system

Pathology

Gerald Arthur Grant

Modulation of the Blood-Tumor Barrier Through Targeted Suppression of Claudin 5

Brain, nervous system

Dimiter Dimitrov

Antibody therapeutics against biodefense-related diseases

Brain, nervous system

Eric Freed

U.S.-India Joint Working Group on the Prevention of Sexually Transmitted Diseases and HIV/AIDS via OAR Intramural to India grant

Brain, nervous system

Larry Keefer

Diazeniumdiolates as Broad-Spectrum Anticancer Agents

Brain, nervous system

Shakti H Ramkissoon

ALK signaling in CNS development, ischemic brain injury and gliomagenesis

Brain, nervous system

Susan Bates

Clinical Studies to Circumvent Drug Resistance

Brain, nervous system

Hemant K. Roy

The role of ATRX and H3.3 mutations in pediatric glioblastoma

Brain, nervous system

Pediatric oncology or childhood cancer

Zeng-Jie Yang

Leukotriene-Induced Nestin Expression Promotes Medulloblastoma Tumorigenesis

Brain, nervous system